Candesic partner Marc Kitten quoted in the latest HBI issue By Marc Kitten
https://www.healthcarebusinessinternational.com/domusvi-robustly-denies-wrongdoing-while-orpea-ramps-up-recruitment/

Candesic partner Marc Kitten shares his point of view in the latest Healthcare Business International issue.

Marc Kitten comments on how providers can restore their reputation after facing allegations and what challenges France`s elderly care sector is currently facing.
 

Click on the link to subscribe & read the article.

About

Candesic is a leading strategy consultancy head-quartered in London, serving private operators, investors, and public sector organisations.

Privacy

Privacy Policy

News & Publications

Candesic proudly advised on Kester Capital investment
Candesic proudly advised on Kester Capital fifth investment in the life sciences sector into MAP Patient Access Limited, a specialist in market access consulting services to the pharmaceutical and biotech sectors. The mission of MAP Patient Access Limited is to make it easier for patients to access ground-breaking medicines, devices, and diagnostics. In addition to its expertise in rare and orphan diseases, it has a proven track record of helping its clients navigate increasingly complex healthcare reimbursement pathways.

HealthTechX Global 2023 was quite the event!
Thanks to all HealthTechX Global 2023- it was quite the event!

Candesic visits Imperial College Business School ‎
This week our team visited Imperial College Business School. **Candesic** is a leading strategy consultancy providing CEO level clarity with R&D level insights for over 21 years.

© Candesic 2023